Circulating transforming growth factor β1 and coronary artery disease

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cardiovascular Research

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0008-6363(97)00033-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Active Macrophage-Associated TGF-f3 Co-Localizes with Type I Procollagen Gene Expression in Atherosclerotic Human Pulmonary Arteries

  2007cited by this paper
• Active and acid-activatable TGF-β in human sera, platelets and plasma

  1995cited by this paper
• The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

  1995cited by this paper
• Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin

  1995cited by this paper
• Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner.

  1995cited by this paper
• Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator

  1995cited by this paper
• Transforming Growth Factor Betal and Beta2 Induce Down-Modulation of Thrombomodulin in Human Umbilical Vein Endothelial Cells

  1995cited by this paper
• The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta.

  1995cited by this paper
• Transforming growth factor-beta and the protection from cardiovascular injury hypothesis.

  1995cited by this paper
• Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice

  1994cited by this paper
• [12] Role of transforming growth factor β and decorin in controlling fibrosis

  1994cited by this paper
• Transforming Growth Factor β in Tissue Fibrosis

  1994cited by this paper
• Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.

  1994cited by this paper
• Bimodal effect of transforming growth factor-beta on insulin secretion in MIN6 cells.

  1994cited by this paper
• Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion.

  1994cited by this paper
• Determinants of severity of coronary artery disease in Australian men and women.

  1994cited by this paper
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.

  1994cited by this paper
• Transforming growth factor-beta in cardiac ontogeny and adaptation.

  1993cited by this paper
• Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

  1993cited by this paper
• Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)

  1993cited by this paper
• Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.

  1992cited by this paper
• Transforming Growth Factor β (TGF-β)Inhibits Expression of Fibrinogen and Factor VII in a Hepatoma Cell Line

  1992cited by this paper
• Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma

  1992cited by this paper
• Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1.

  1991cited by this paper
• Regulation of acute phase reaction by transforming growth factor beta in cultured murine hepatocytes.

  1991cited by this paper
• Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta.

  1988cited by this paper

• Exploring the prediction model and core genes for coronary artery disease in non-obese steatotic liver disease patients.

  2026cites this paper
• Vascular smooth muscle cell phenotypic switching in atherosclerosis

  2024cites this paper
• Insights into bone morphogenetic proteins in cardiovascular diseases

  2023cites this paper
• ROLE OF THE TRANSFORMING GROWTH FACTOR β1 IN THE GENESIS OF ARTERIAL HYPERTENSION AND ITS COMPLICATIONS

  2021cites this paper
• Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A SystematicReview of RCTs and Insight into the Underlying Mechanism

  2020cites this paper
• The role of bone morphogenetic protein signaling in vascular calcification.

  2020cites this paper
• Transforming Growth Factor Beta 1 and Vascular Risk in Alcoholics.

  2019cites this paper
• Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment

  2019cites this paper
• TGFβ, smooth muscle cells and coronary artery disease: a review

  2019cites this paper
• Transforming Growth Factor β1 (TGF-β1) Appears to Promote Coronary Artery Disease by Upregulating Sphingosine Kinase 1 (SPHK1) and Further Upregulating Its Downstream TIMP-1

  2018cites this paper
• Detection of transforming growth factor beta 1 in normal dogs and dogs with degenerative mitral valve disease

  2018cites this paper
• NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.

  2017cites this paper
• Platelet and Immunity in Transfusion Medicine

  2017cites this paper
• Genome-Wide Linkage Analysis of Large Multiple Multigenerational Families Identifies Novel Genetic Loci for Coronary Artery Disease

  2017cites this paper
• The role of lnc-DC long non-coding RNA and SOCS1 in the regulation of STAT3 in coronary artery disease and type 2 diabetes mellitus.

  2017cites this paper
• New methodologies to accurately assess circulating active transforming growth factor‐&bgr;1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices

  2017cites this paper
• Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk

  2017cites this paper
• Polymorphism of the C-509 gene of TGFB1 and the risk of obliterative atherosclerosis of lower limb arteries

  2017cites this paper
• Association of Soluble Fibrinogen-like Protein 2 with the Severity of Coronary Artery Disease.

  2016cites this paper
• The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease

  2016cites this paper
• A novel collagen/platelet-rich plasma (COL/PRP) scaffold: preparation and growth factor release analysis

  2016cites this paper
• Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.

  2015cites this paper
• Clinical outcome in patients with acute coronary syndrome and outward remodeling is associated with a predominant inflammatory response

  2014cites this paper
• Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.

  2014cites this paper
• Combining insoluble and soluble factors to steer stem cell fate.

  2014cites this paper
• TGF-β and Cardiovascular Disorders

  2013cites this paper
• Inflammation’s Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder

  2013cites this paper
• Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

  2013cites this paper
• N-Acetylcysteine Effects on Transforming Growth Factor-β and Tumor Necrosis Factor-α Serum Levels as Pro-Fibrotic and Inflammatory Biomarkers in Patients Following ST-Segment Elevation Myocardial Infarction

  2013cites this paper
• Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload.

  2012cites this paper
• The T29C polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with genetic susceptibility to acute coronary syndrome in Mexican patients.

  2012cites this paper
• TGFβ Signaling and Cardiovascular Diseases

  2012cites this paper
• TGF‐β1 content in atherosclerotic plaques, TGF‐β1 serum concentrations and incident coronary events

  2012cites this paper
• Association of Transforming Growth Factor-&bgr;1 Gene Polymorphisms With Genetic Susceptibility to Acute Myocardial Infarction

  2011cites this paper
• Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.

  2011cites this paper
• Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE−/− Mice

  2011cites this paper
• Genetics of Hypertension and Cardiovascular Disease

  2011cites this paper
• Changes in transforming growth factor β and its receptors’ mRNA expression in monocytes from patients with acute coronary syndromes

  2010cites this paper
• Genetic Determinants of Osteoporosis: Common Bases to Cardiovascular Diseases?

  2010cites this paper
• Interleukin-17–Dependent Autoimmunity to Collagen Type V in Atherosclerosis

  2010cites this paper
• Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice.

  2009cites this paper
• Marcadores pro y antiinflamatorios en la enfermedad arterial coronaria y el síndrome isquémico coronario agudo

  2009cites this paper
• Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits.

  2009cites this paper
• Exogenous transforming growth factor beta1 replacement and fertility in male Tgfb1 null mutant mice.

  2009cites this paper
• The Role of Interleukin-6 and Transforming Growth Factor-β1 in Predicting Restenosis within Stented Infarct-Related Artery

  2009cites this paper
• Stem cells, microenvironment mechanics, and growth factor activation.

  2009cites this paper
• Thrombospondin-Dependent Activation of Latent TGF-β in Fibrosis and Disease

  2008cites this paper
• In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.

  2008cites this paper
• Platelets, but not erythrocytes, significantly affect cytokine release and scaffold contraction in a provisional scaffold model

  2008cites this paper
• Activation of platelet-rich plasma using soluble type I collagen.

  2008cites this paper
• Chocolate at heart: the anti-inflammatory impact of cocoa flavanols.

  2008cites this paper
• Inflammatory cytokine gene variants in coronary artery disease patients in Greece

  2008cites this paper
• Transforming Growth Factor-beta 1 Gene Polymorphisms According to Diabetic Nephropathy in Type 2 Diabetes

  2007cites this paper
• Cyclooxygenase-2 inhibitor ameliorates ureteric damage in rats with obstructed uropathy.

  2007cites this paper
• TGF-β and atherosclerosis in man

  2007cites this paper
• TGF-β1: a novel target for cardiovascular pharmacology

  2007cites this paper
• TGF-&bgr;1 Polymorphisms and Risk of Myocardial Infarction and Stroke: The Rotterdam Study

  2006cites this paper
• Renal handling of adipokines.

  2006cites this paper
• A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis.

  2006cites this paper
• The Anti-inflammatory Properties of Cocoa Flavanols

  2006cites this paper
• Different Effects of Simvastatin and Losartan on Cytokine Levels in Coronary Artery Disease

  2006cites this paper
• Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.

  2005cites this paper
• Up-regulation of acyl-coenzyme A:cholesterol acyltransferase-1 by transforming growth factor-beta1 during differentiation of human monocytes into macrophages.

  2004cites this paper
• Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.

  2004cites this paper
• Genetic Determinants of Susceptibility, Prognosis and Treatment in Heart Failure

  2004cites this paper
• DISCOURS INAUGURAL DE LA 24 ÈME JOURNÉE NATIONALE DE BIOLOGIE CLINIQUE

  2004cites this paper
• Circulating Transforming Growth Factor-β1, Lipoprotein(a) and Cellular Adhesion Molecules in Angiographically Assessed Coronary Artery Disease

  2003cites this paper
• Cocoa Flavonols and Procyanidins Promote Transforming Growth Factor-β1 Homeostasis in Peripheral Blood Mononuclear Cells1

  2003cites this paper
• Transforming growth factor (TGF)‐β1 inversely related to vascular cell adhesion molecule‐1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF‐β1?

  2002cites this paper
• Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin.

  2002cites this paper
• The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives

  2002cites this paper
• Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation

  2002cites this paper
• TGF-β1 gene polymorphisms in patients with end-stage heart failure

  2001cites this paper
• Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans

  2001cites this paper
• Relationship between cytokine levels and coronary artery disease in women.

  2001cites this paper
• TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-γ

  2001cites this paper
• Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice

  2001cites this paper
• Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease

  2001cites this paper
• Endopyelotomy Failure Is Associated with Reduced Urinary Transforming Growth Factor-β1 Levels in Patients with Upper Urinary Tract Obstruction

  2001cites this paper
• Inhibition of Transforming Growth Factor-&bgr; Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice

  2001cites this paper
• Increased plasma concentrations of TGF‐β1 after hormone replacement therapy

  2000cites this paper
• Plasma Inflammatory Markers and T-Lymphocytes Are Activated in Angina Pectoris

  2000cites this paper
• TGF-β in blood: a complex problem

  2000cites this paper
• Weitere kardiovaskuläre Risikofaktoren

  2000cites this paper
• Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese.

  2000cites this paper
• Fettstoffwechsel, Übergewicht und Ernährung, Diabetes

  2000cites this paper
• Plasma β‐Amyloid Peptide, Transforming Growth Factor‐β1, and Risk for Cerebral Amyloid Angiopathy

  2000cites this paper
• Emerging noninvasive biochemical measures to predict cardiovascular risk.

  1999cites this paper
• Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients

  1999influential citation
• The significance of platelet-derived growth factors for proliferation of vascular smooth muscle cells.

  1999cites this paper
• Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

  1999cites this paper
• Transforming Growth Factor-β1 (TGF-β1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-β Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-β Itself With High Specificity

  1999cites this paper
• Failed Endopyelotomy: Low Expression of TGFβ Regardless of the Presence or Absence of Crossing Vessels

  1999cites this paper
• Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.

  1999cites this paper
• 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase.

  1999cites this paper
• Molecular genetics of coronary artery disease: measuring the phenotype.

  1998cites this paper
• Biologic markers as predictors of cardiovascular disease.

  1998cites this paper
• Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation.

  1998cites this paper
• A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease.

  1998cites this paper
• Endopyelotomy failure is associated with reduced transforming growth factor-beta.

  1998cites this paper